Tag: Hester Biosciences
Hester’s consolidated profit stands at Rs. 6.94 crore in Q2 FY23
The company has garnered the revenue of Rs. 77.60 crores during the period ended September 30, 2022
Hester plans capacity expansion for Goat Pox vaccine, to manufacture Lumpy...
The company will acquire the technology for Lumpy Skin disease vaccine from ICAR-IVRI to manufacture and commercialize the Lumpy Skin disease Vaccine
Hester Biosciences ventures into pet care industry
Hester’s comprehensive knowledge of animal biology, cutting-edge R&D capabilities, and four-decade-long experience in animal healthcare gives them an advantage
Hester Biosciences appoints Priya Gandhi as Executive Director
Priya has played an active role in setting up the manufacturing plant and the business activities in Hester Africa..........................